Xinyuan Ding

机构：Zhejiang Chinese Medical University, Children's Hospital of Los Angeles, Shenzhen Maternity and Child Healthcare Hospital, Suzhou Municipal Hospital, Southern Medical University, Nanjing Medical University · ORCID：0000-0002-8982-6807

发表论文 47 篇 · 总被引 710 次 · h-index 16

代表论文

• Hippo/YAP signaling choreographs the tumor immune microenvironment to promote triple negative breast cancer progression via TAZ/IL-34 axis (2021 · Cancer Letters · 被引 56)
• GPR120 induces regulatory dendritic cells by inhibiting HK2-dependent glycolysis to alleviate fulminant hepatic failure (2021 · Cell Death and Disease · 被引 47)
• CircRNA DDX21 acts as a prognostic factor and sponge of miR‐1264/QKI axis to weaken the progression of triple‐negative breast cancer (2022 · Clinical and Translational Medicine · 被引 23)
• Bi-directional metabolic reprogramming between cancer cells and T cells reshapes the anti-tumor immune response (2025 · PLoS Biology · 被引 18)
• Triterpenoid saponins from Ilex cornuta protect H9c2 cardiomyocytes against H2O2-induced apoptosis by modulating Ezh2 phosphorylation (2020 · Journal of Ethnopharmacology · 被引 17)
• The Impact of a Multifaceted Pharmacist-Led Antimicrobial Stewardship Program on Antibiotic Use: Evidence From a Quasi-Experimental Study in the Department of Vascular and Interventional Radiology in a Chinese Tertiary Hospital (2022 · Frontiers in Pharmacology · 被引 14)